ArticleScientific reports2016

Predictive Immunohistochemical Markers Related to Drug Selection for Patients Treated with Sunitinib or Sorafenib for Metastatic Renal Cell Cancer.

Xin Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.